Media Center

What’s new at VaxInnate? Our technology. Our vaccines. Our approach to addressing some of the world's most significant public health threats.

Press Releases

09/25/2007	VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine Company’s First Clinical Trial Studies Vaccine Based on New Vaccine Technology
07/23/2007	VaxInnate Awarded NIH Funding for Collaborative Dengue Fever Vaccine Development Award based on TLR technology platform’s application in developing vaccines for Flavivirus and other infectious diseases
06/06/2007	Two Significant Hires Round-Out VaxInnate’s Core Management Team Newly appointed CFO and COO bring extensive experience to support and further the company’s vaccine development programs
03/23/2007	David Taylor, MD, Joins VaxInnate as Chief Medical Officer Dr. Taylor's Extensive Experience in Infectious Disease and Vaccine Research Will Support Advancement of Avian and Seasonal Influenza, Malaria Vaccines
12/01/2006	UTMB receives $9.5M grant from Gates foundation help study and develop VaxInnate flu vaccine. VaxInnate is a UTMB-selected subcontractor on the grant.
11/30/2006	U.S. Congressman Rush Holt Visits VaxInnate to Announce Govt. Funding for Collaborative Malaria Vaccine Development Defense Appropriations Act awards $1million to VaxInnate for vaccine research
10/25/2006	VaxInnate Secures $40 Million Series C Financing Funds will support commercial development of novel human and avian flu vaccines
[+] View All

6/17-6/20/2008 San Diego, California	BIO International Convention 2008 The BIO International Convention is the largest biotechnology event in the world, featuring keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. The convention helps BIO fulfill its mission to help grow the global biotech industry. Learn more »

10/8-10/13/2007 Capetown, South Africa	Keystone Symposium: Challenges of Global Vaccine Development This symposium will bring together scientists, physicians and students from the developed and developing world to discuss the advances in (1) understanding the generation of effective systemic and mucosal immunity at a cellular and organ system level; (2) new technologies for prophylactic and therapeutic immunization, including those useful for resource-poor settings; (3) understanding the unique requirements to stimulate immunity in early childhood; (4) pre-clinical models; and (5) correlates of protection. Learn more »

8/21-8/25/2007 Rio de Janeiro, Brazil	ImmunoRio, the International Congress of Immunology; The 13^th International Congress of Immunology brings together immunology experts from around the world to discuss and present the latest research and advancements in immunology. Learn more »

[+] View All